Improvements in Cardiometabolic Risk Factors by Weight Reduction: A Post Hoc Analysis of Adults With Obesity Randomly Assigned to Tirzepatide.

Journal:

Annals of Internal Medicine

Published:

2025-06-24

DOI:

10.7326/annals-24-02623

Affiliations:

8

Authors:

9

Go to article

Institutions	Authors	Share
Lilly, United States of America (USA)	4.000000	0.44
Eli Lilly S.A., Ireland	1.000000	0.11
Eli Lilly and Company France, France	1.000000	0.11
University of Glasgow, United Kingdom (UK)	1.000000	0.11
Yale New Haven Hospital (YNHH), United States of America (USA)	0.500000	0.06
Yale University, United States of America (USA)	0.500000	0.06
St. Michael's Hospital, Canada	0.500000	0.06
University of Toronto (U of T), Canada	0.500000	0.06

Interested in Pharmacology and Pharmaceutical Sciences?